Literature DB >> 35958469

Relationship between lipid profile, inflammatory and endothelial dysfunction biomarkers, and type 1 diabetes mellitus: a case-control study.

Juma Alkaabi1, Charu Sharma1, Javed Yasin1, Bachar Afandi2, Salem A Beshyah3, Raya Almazrouei2, Ahmed Alkaabi4, Sania Al Hamad5, Luai A Ahmed6, Rami Beiram7, Elhadi H Aburawi5.   

Abstract

OBJECTIVE: Inflammation is a major factor in endothelial dysfunction (ED) which is the earliest predictor of cardiovascular disease and premature mortality in type 1 diabetes mellitus (T1DM) patients. This study aimed to describe the possible relationship between plasma lipids and inflammatory and ED biomarkers in young Emirati patients with and without T1DM.
METHODS: This case-control study included 158 patients with T1DM and 157 healthy controls from the local population of the United Arab Emirates (UAE). Anthropometric data, clinical variables, lipid profiles, liver enzymes, HbA1c, inflammatory, and ED biomarkers were measured for all participants using sophisticated techniques and assays.
RESULTS: The mean ages ± SD of patients with T1DM and healthy controls was 19.3 ± 6.4 years (59.5% females) and 9.2 ± 6.8 years (61.5% females), respectively. The mean duration of T1DM was 9.3 ± 5.7 years, with HbA1c of 8.9 ± 2.1%. BMI, WC, SBP, and DBP significantly differed between the two groups. The mean lipid profiles (HDL, TG, TC, ApoA, and ApoB), liver enzymes (GGT, ALT), inflammatory (IL-6, adiponectin, TNF-α, hs-CRP), and ED biomarker levels (ICAM-1, VCAM-1, selectin, and ET-1) were also significantly different between patients and controls. Based on Spearman's rank and logistic regression analysis, there was a significant association between elevated lipid profile, liver enzymes, inflammatory markers, and ED markers in T1DM patients compared to controls. Among the biomarkers studied, ApoA, ApoB, and TC were significantly increased in T1DM patients compared to controls.
CONCLUSION: This study revealed a strong association between an elevated lipid profile and inflammatory and ED markers with T1DM, which could lead to cardiovascular events in the UAE population. AJTR
Copyright © 2022.

Entities:  

Keywords:  Type 1 diabetes mellitus; cardiovascular risk; endothelial dysfunction; inflammation; lipid profile

Year:  2022        PMID: 35958469      PMCID: PMC9360849     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  28 in total

1.  Predicting major outcomes in type 1 diabetes: a model development and validation study.

Authors:  Sabita S Soedamah-Muthu; Yvonne Vergouwe; Tina Costacou; Rachel G Miller; Janice Zgibor; Nish Chaturvedi; Janet K Snell-Bergeon; David M Maahs; Marian Rewers; Carol Forsblom; Valma Harjutsalo; Per-Henrik Groop; John H Fuller; Karel G M Moons; Trevor J Orchard
Journal:  Diabetologia       Date:  2014-09-04       Impact factor: 10.122

2.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Authors:  Pouya Saeedi; Inga Petersohn; Paraskevi Salpea; Belma Malanda; Suvi Karuranga; Nigel Unwin; Stephen Colagiuri; Leonor Guariguata; Ayesha A Motala; Katherine Ogurtsova; Jonathan E Shaw; Dominic Bright; Rhys Williams
Journal:  Diabetes Res Clin Pract       Date:  2019-09-10       Impact factor: 5.602

3.  Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study.

Authors:  Nina Tolonen; Carol Forsblom; Ville-Petteri Mäkinen; Valma Harjutsalo; Daniel Gordin; Maija Feodoroff; Niina Sandholm; Lena M Thorn; Johan Wadén; Marja-Riitta Taskinen; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2014-05-30       Impact factor: 19.112

4.  Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases.

Authors:  Susanna C Larsson; Alice Wallin; Niclas Håkansson; Otto Stackelberg; Magnus Bäck; Alicja Wolk
Journal:  Int J Cardiol       Date:  2018-03-24       Impact factor: 4.164

5.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.

Authors:  Matthew J McQueen; Steven Hawken; Xingyu Wang; Stephanie Ounpuu; Allan Sniderman; Jeffrey Probstfield; Krisela Steyn; John E Sanderson; Mohammad Hasani; Emilia Volkova; Khawar Kazmi; Salim Yusuf
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

Review 6.  Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes.

Authors:  Sowmya Krishnan; Kevin R Short
Journal:  J Cardiometab Syndr       Date:  2009

7.  LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

Authors:  C Hero; A-M Svensson; P Gidlund; S Gudbjörnsdottir; B Eliasson; K Eeg-Olofsson
Journal:  Diabet Med       Date:  2015-11-11       Impact factor: 4.359

8.  Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes.

Authors:  Etienne Sochett; Damien Noone; Michael Grattan; Cameron Slorach; Rahim Moineddin; Yesmino Elia; Farid H Mahmud; David B Dunger; Neil Dalton; David Cherney; James Scholey; Heather Reich; John Deanfield
Journal:  Cytokine       Date:  2017-07-29       Impact factor: 3.861

9.  Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids.

Authors:  Muhammad Bayu Sasongko; Tien Y Wong; Thanh T Nguyen; Ryo Kawasaki; Alicia Jenkins; Jonathan Shaw; Jie Jin Wang
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

10.  Children with type 1 diabetes have elevated high-sensitivity C-reactive protein compared with a control group.

Authors:  Pilar Pérez-Segura; Olaya de Dios; Leticia Herrero; Claudia Vales-Villamarín; Isabel Aragón-Gómez; Teresa Gavela-Pérez; Carmen Garcés; Leandro Soriano-Guillén
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.